Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07294053 · ClinicalTrials.gov registry record · NA
Sugary Drink Labeling Study
A NA study of Health Behavior, sponsored by University of North Carolina, Chapel Hill.
- Recruiting
- Registry status
- NA
- Development phase
- 543
- Enrollment target
- 1
- Study location
NCT07294053: Recruiting NA study of Health Behavior, sponsored by University of North Carolina, Chapel Hill.
NCT07294053 is a NA study of Health Behavior that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 543 participants, below the 2,177-participant average among 65 other Health Behavior trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07294053, a NA study of Health Behavior, is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.
- RECRUITING
- Registry status
- NA
- Development phase
- 543 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to examine the effects of added sugar warning labels on sugary drinks. Participants will be assigned to view either added sugar warning labels or control labels, applied on sugary drinks in an experimental store. Participants will shop for beverages in the store and take a computer survey at 4 visits spaced approximately 1 week apart.
Primary Outcome
Measured using purchase data for sugary drinks, defined as drinks that contain at least 20% of the daily value for added sugar. The total amount of added sugars (in grams) in all sugary drinks purchased will be calculated.
Conditions Studied
Interventions
- BEHAVIORAL Added sugar warning
- BEHAVIORAL Control label
Study Locations (1)
North Carolina
- The University of North Carolina at Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 543 participants |
| Start Date | 2026-02-16 |
| Est. Completion | 2028-02 |
| Phase | NA |
What NCT07294053 shows while recruiting
NCT07294053 is an interventional study that assigns participants to a tested intervention. The registered 543 participants enrollment target is mid-sized for trials with a published cap, below the 2,177-participant average among 65 other Health Behavior trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Health Behavior appearing as the primary indexed condition, and to 2 interventions - of which Added sugar warning is the first listed.
NCT07294053 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT07294053 about?
NCT07294053 is a clinical study titled "Sugary Drink Labeling Study". This study aims to examine the effects of added sugar warning labels on sugary drinks. Participants will be assigned to view either added sugar warning labels or control labels, applied on sugary drinks in an experimental store. Participants will shop for beverages in the store and take a computer s...
What is the current status of trial NCT07294053?
This trial is currently recruiting. It is a NA study. The enrollment target is 543 participants. The study started on 2026-02-16. Estimated completion is 2028-02.
What conditions does trial NCT07294053 study?
This clinical trial studies the following conditions: Health Behavior.
What interventions are being tested in trial NCT07294053?
The interventions under investigation include: Added sugar warning (BEHAVIORAL), Control label (BEHAVIORAL).
Who is sponsoring clinical trial NCT07294053?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07294053 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Health Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07294053's enrollment target sits among peer trials
543 19th of 65 higher than 47 of 65 other Health Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Health Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients
RECRUITING · NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
The Validation Study of Bioelectronics
RECRUITING · NA
-
A Digital Intervention to Promote Preschool Nutrition and Activity: The eHEROs Study
RECRUITING · NA
-
Evaluation Of Cardiovascular Health Outcomes Among Survivors 2
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03127761 · 544 participants
Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
- NCT04378790 · 544 participants · Phase 3
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
- NCT06118502 · 544 participants · NA
A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse
- NCT06170437 · 544 participants · NA
Smoke-free Home Study in Subsidized Housing
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI